Upstream Bio (UPB) Receivables - Other (2023 - 2026)

Upstream Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 34.22% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 34.22% YoY), while the FY2025 annual figure was $1.7 million, up 191.53% from the prior year.
• Receivables - Other was $1.6 million for Q1 2026 at Upstream Bio, down from $1.7 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.7 million in Q2 2025 to a low of $138000.0 in Q4 2023.
• Historically, Receivables - Other has averaged $1.1 million across 4 years, with a median of $1.4 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Receivables - Other jumped 310.87% in 2024, then surged 34.22% in 2026.
• A 4-year view of Receivables - Other shows it stood at $138000.0 in 2023, then surged by 310.87% to $567000.0 in 2024, then jumped by 191.53% to $1.7 million in 2025, then retreated by 4.84% to $1.6 million in 2026.
• The last three Receivables - Other figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.